These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16023508)
21. [Adefovir dipivoxil treatment of hepatic cirrhosis complicated with hepatitis B virus associated glomerulonephritis]. Li DF; Jin ZJ; Chen YS; Qiao LM; Zhou J Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):349-51. PubMed ID: 18510846 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis C: who should be treated? Campbell MS Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):77-9. PubMed ID: 16447299 [No Abstract] [Full Text] [Related]
23. [Treatment of hepatitis B and C virus infection]. Trautwein C; Tacke F Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S87-9. PubMed ID: 12817332 [No Abstract] [Full Text] [Related]
24. [New domestic phospholipid preparation "Fosfogliv" as an effective treatment for patients with acute viral hepatitis]. Uchaĭkin VF; Luchshev VI; Zharov SN; Kovalev OB; Ipatova OM; Tikhonova EG; Torkhovskaia TI; Kniazhev VA; Dunaevskiĭ OA; Archakov AI Klin Med (Mosk); 2000; 78(5):39-42. PubMed ID: 10881509 [TBL] [Abstract][Full Text] [Related]
25. [When and how to treat hepatitis B and C?]. Pache I; Hess J; Gonvers JJ; Moradpour D Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818 [TBL] [Abstract][Full Text] [Related]
26. Extrahepatic manifestations of chronic viral hepatitis. Willson RA Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930 [No Abstract] [Full Text] [Related]
28. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers. Renou C; Cadranel JF; Pariente A; Pénaranda G; Bourlière M; Halfon P; Igual JP; Harafa A; Muller P; Bertrand JJ; Laugier R Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1235-7. PubMed ID: 18989147 [TBL] [Abstract][Full Text] [Related]
29. [Hepatitis A, B, C, D, E - What treatment options for whom?]. Manns M Drug Res (Stuttg); 2014 Nov; 64 Suppl 1():S18-9. PubMed ID: 25423421 [No Abstract] [Full Text] [Related]
30. Viral hepatitis in 2011: a major step forward. Marcellin P Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130 [No Abstract] [Full Text] [Related]
31. [The role of interferon in the treatment of viral hepatitis and its perspective]. Zhang DF Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448 [No Abstract] [Full Text] [Related]
32. [The combination administration of interferon in viral hepatitis]. Zhao GD; Xie Q Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449 [No Abstract] [Full Text] [Related]
33. Highlights from the 60th Annual Meeting of the AASLD. Mayor S Lancet Infect Dis; 2010 Jan; 10(1):8. PubMed ID: 20162852 [No Abstract] [Full Text] [Related]
34. Providers face big challenge: HIV/HCV co-infection. Hepatitis B infection also problematic. AIDS Alert; 2006 Aug; 21(8):85-7. PubMed ID: 16913040 [No Abstract] [Full Text] [Related]
36. Antiviral therapy: quo vadis? De Clercq E Future Med Chem; 2010 Jul; 2(7):1049-53. PubMed ID: 21426154 [No Abstract] [Full Text] [Related]
37. Treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia--anti-viral therapy vs rituximab. Bruchfeld A; Saadoun D; Cacoub P Rheumatology (Oxford); 2006 Jun; 45(6):783-4; author reply 784-5. PubMed ID: 16679341 [No Abstract] [Full Text] [Related]
38. Management of hepatitis B in special patient populations. Wang HS; Han SH Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028 [TBL] [Abstract][Full Text] [Related]
39. Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir. Lê MP; Gervais A; Le Beller C; Long K; Larrouy L; Papy E; Mal H; Descamps D; Peytavin G J Antimicrob Chemother; 2013 May; 68(5):1208-9. PubMed ID: 23335198 [No Abstract] [Full Text] [Related]